Global Molecular Cytogenetics Market 2017-2021 - Product Image

Global Molecular Cytogenetics Market 2017-2021

  • ID: 4339912
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Applied Spectral Imaging
  • Bio-Rad Laboratories
  • CytoTest
  • Illumina
  • MetaSystems
  • MORE
About Molecular Cytogenetics

Molecular cytogenetics is the combination of molecular biology and cytogenetics. It increases the resolution and diagnostic utility of cytogenetic analysis. FISH, which is molecular cytogenetic technique, is used for the identification of genetic disorders and the detection of chromosomal genetic abnormalities. CGH, which is also a molecular cytogenetic technique, is used to analyze the variations in copy numbers of the test sample by comparing it with the normal reference sample without using any cell culture.

The analysts forecast the global molecular cytogenetics market to grow at a CAGR of 10.94% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global molecular cytogenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of molecular cytogenetics products.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Molecular Cytogenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
Other prominent vendors
  • Applied Spectral Imaging
  • Biological Industries
  • CytoTest
  • Cytognomix
  • F. Hoffmann-La Roche
  • Illumina
  • Leica Biosystems
  • MetaSystems
  • Oxford Gene Technology
  • PerkinElmer
  • SciGene
Market drivers
  • Growing aging population and increasing prevalence of chronic diseases
  • For a full, detailed list, view the full report
Market challenges
  • Advent of alternative techniques
  • For a full, detailed list, view the full report
Market trends
  • Increased focus on targeted cancer treatment
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Applied Spectral Imaging
  • Bio-Rad Laboratories
  • CytoTest
  • Illumina
  • MetaSystems
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 05: Segmentation by end-users
  • Overview
  • Clinical and research laboratories
  • Pharmaceutical and biotechnology companies
  • Others
PART 06: Segmentation by geography
  • Overview
  • Americas
  • EMEA
  • APAC
PART 07: Decision framework

PART 08: Drivers and challenges
  • Market drivers
  • Market challenges
PART 09: Market trends
  • Increased focus on targeted cancer treatment
  • Rising demand in emerging markets
  • Transition from FISH to array-based technique
PART 10: Vendor landscape
  • Competitive scenario
  • Investment opportunity
PART 11: Key vendor analysis
  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 12: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Molecular cytogenetics: Applications
Exhibit 02: Global molecular cytogenetics market: Overview 2016-2021
Exhibit 03: Global molecular cytogenetics market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global molecular cytogenetics market: Segmentation by end-users 2016-2021 (% share)
Exhibit 06: Global molecular cytogenetics market: Overview of segmentation by end-users
Exhibit 07: Global molecular cytogenetics market by clinical and research laboratories 2016-2021 ($ millions)
Exhibit 08: Global molecular cytogenetics market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 09: Global molecular cytogenetics market by others 2016-2021 ($ millions)
Exhibit 10: Number of hospitals in various countries 2014
Exhibit 11: Global molecular cytogenetics market: Segmentation by geography 2016-2021 (% share)
Exhibit 12: Global molecular cytogenetics market: Overview of segmentation by geography
Exhibit 13: Molecular cytogenetics market in Americas 2016-2021 ($ millions)
Exhibit 14: Prevalence of cancer in US 2015 (millions)
Exhibit 15: Molecular cytogenetics market in EMEA 2016-2021 ($ millions)
Exhibit 16: Molecular cytogenetics market in APAC 2016-2021 ($ millions)
Exhibit 17: Estimated investments in R&D by India and China 2010-2030
Exhibit 18: Preventive screening and diagnosis: Essential elements
Exhibit 19: Advantages of FISH over conventional methods
Exhibit 20: FISH and DMI: Comparison
Exhibit 21: Investments in R&D in APAC and GDP contribution 2016
Exhibit 22: FISH, CGH, and array CGH: Comparative analysis
Exhibit 23: Global molecular cytogenetics market: Investment potential
Exhibit 24: Abbott Laboratories: Overview
Exhibit 25: Abbott Laboratories: Strength analysis
Exhibit 26: Abbott Laboratories: Strategy assessment
Exhibit 27: Abbott Laboratories: Opportunity assessment
Exhibit 28: Agilent Technologies: Overview
Exhibit 29: Agilent Technologies: Strength analysis
Exhibit 30: Agilent Technologies: Strategy assessment
Exhibit 31: Agilent Technologies: Opportunity assessment
Exhibit 32: Bio-Rad Laboratories: Overview
Exhibit 33: Bio-Rad Laboratories: Strength analysis
Exhibit 34: Bio-Rad Laboratories: Strategy assessment
Exhibit 35: Bio-Rad Laboratories: Opportunity assessment
Exhibit 36: Thermo Fisher Scientific: Overview
Exhibit 37: Thermo Fisher Scientific: Strength analysis
Exhibit 38: Thermo Fisher Scientific: Strategy assessment
Exhibit 39: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Applied Spectral Imaging
  • Bio-Rad Laboratories
  • CytoTest
  • Illumina
  • MetaSystems
  • MORE
New Report Released: – Global Molecular Cytogenetics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global molecular cytogenetics market: Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Applied Spectral Imaging, Biological Industries, CytoTest, Cytognomix, F. Hoffmann-La Roche, Illumina, Leica Biosystems, MetaSystems, Oxford Gene Technology, PerkinElmer, and SciGene.

Commenting on the report, an analyst from the research team said: “One trend in the market is increased focus on targeted cancer treatment. Targeted cancer treatment blocks the growth of cancerous cells by interfering with specific cell molecules that are required for carcinogenesis and tumor, instead of interfering with all rapidly dividing cells. The growing prevalence of cancer among men and women is driving the constant development of cancer treatment. Chemotherapy is an important part of cancer treatment.”

According to the report, one driver in the market is growing aging population and increasing prevalence of chronic diseases. The aging population is increasing globally. it has been estimated that the number of people above the age of 65 is expected to increase by more than 200% by 2050 from 2010. With the continuing decline in mortality rates among the aging population, the ratio of aging people and their life expectancy are increasing. This is due to the decline in fertility rates and improvement in life expectancy rates.

Further, the report states that one challenge in the market is advent of alternative techniques. Despite the significant performance advantages and cost benefits of molecular cytogenetics when compared with amplification assays or other molecular in-vitro diagnostic (IVD) tests, FISH's limitation of an error-prone and complex procedural nature, particularly for complex samples such as mucoid respiratory samples or environmental samples, have prevented its routine use for IVD. Some advancements have been made for the removal of traditional DNA probes with peptide probes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Applied Spectral Imaging
  • Biological Industries
  • CytoTest
  • Cytognomix
  • F. Hoffmann-La Roche
  • Illumina
  • Leica Biosystems
  • MetaSystems
  • Oxford Gene Technology
  • PerkinElmer
  • SciGene
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll